CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alnylam Pharmaceuticals, Inc. Company Snapshot
Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other companies in this sector in the United States: Xenoport, Inc. (2015 sales of $41.16 million of which 100% was Biopharmaceutical Products), Corium International Inc ($40.92 million of which 100% was Pharmaceutical), and Theravance Biopharma Inc ($42.13 million of which 100% was Human Therapeutics).

Sales Analysis. During the year ended December of 2015, sales at Alnylam Pharmaceuticals were $41.10 million. This is a decrease of 18.7% versus 2014, when the company's sales were $50.56 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alnylam Pharmaceuticals, Inc.
  Stock Performance Chart for Alnylam Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 41.57
(Figures in U.S. Dollars)
1 Week -13.2%   13 Weeks 23.2%  
4 Weeks -39.9%   52 Weeks -61.8%  
 
Alnylam Pharmaceuticals, Inc. Key Data:
  Ticker: ALNY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 41,097,000
(Year Ending Jan 2016).
Employees: 165
  Currency: U.S. Dollars Market Cap: 3,565,302,098
  Fiscal Yr Ends: December Shares Outstanding: 85,766,228
  Share Type: Common Closely Held Shares: 14,677,628
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.